235 related articles for article (PubMed ID: 29987023)
1. Different roles of myocardial ROCK1 and ROCK2 in cardiac dysfunction and postcapillary pulmonary hypertension in mice.
Sunamura S; Satoh K; Kurosawa R; Ohtsuki T; Kikuchi N; Elias-Al-Mamun M; Shimizu T; Ikeda S; Suzuki K; Satoh T; Omura J; Nogi M; Numano K; Siddique MAH; Miyata S; Miura M; Shimokawa H
Proc Natl Acad Sci U S A; 2018 Jul; 115(30):E7129-E7138. PubMed ID: 29987023
[TBL] [Abstract][Full Text] [Related]
2. Identification of Celastrol as a Novel Therapeutic Agent for Pulmonary Arterial Hypertension and Right Ventricular Failure Through Suppression of Bsg (Basigin)/CyPA (Cyclophilin A).
Kurosawa R; Satoh K; Nakata T; Shindo T; Kikuchi N; Satoh T; Siddique MAH; Omura J; Sunamura S; Nogi M; Takeuchi Y; Miyata S; Shimokawa H
Arterioscler Thromb Vasc Biol; 2021 Mar; 41(3):1205-1217. PubMed ID: 33472404
[TBL] [Abstract][Full Text] [Related]
3. Basigin Promotes Cardiac Fibrosis and Failure in Response to Chronic Pressure Overload in Mice.
Suzuki K; Satoh K; Ikeda S; Sunamura S; Otsuki T; Satoh T; Kikuchi N; Omura J; Kurosawa R; Nogi M; Numano K; Sugimura K; Aoki T; Tatebe S; Miyata S; Mukherjee R; Spinale FG; Kadomatsu K; Shimokawa H
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):636-46. PubMed ID: 26916734
[TBL] [Abstract][Full Text] [Related]
4. Basigin mediates pulmonary hypertension by promoting inflammation and vascular smooth muscle cell proliferation.
Satoh K; Satoh T; Kikuchi N; Omura J; Kurosawa R; Suzuki K; Sugimura K; Aoki T; Nochioka K; Tatebe S; Miyamichi-Yamamoto S; Miura M; Shimizu T; Ikeda S; Yaoita N; Fukumoto Y; Minami T; Miyata S; Nakamura K; Ito H; Kadomatsu K; Shimokawa H
Circ Res; 2014 Sep; 115(8):738-50. PubMed ID: 25149188
[TBL] [Abstract][Full Text] [Related]
5. Belumosudil, ROCK2-specific inhibitor, alleviates cardiac fibrosis by inhibiting cardiac fibroblasts activation.
Liu Q; Li HY; Wang SJ; Huang SQ; Yue Y; Maihemuti A; Zhang Y; Huang L; Luo L; Feng KN; Wu ZK
Am J Physiol Heart Circ Physiol; 2022 Jul; 323(1):H235-H247. PubMed ID: 35657612
[TBL] [Abstract][Full Text] [Related]
6. FHL2 prevents cardiac hypertrophy in mice with cardiac-specific deletion of ROCK2.
Okamoto R; Li Y; Noma K; Hiroi Y; Liu PY; Taniguchi M; Ito M; Liao JK
FASEB J; 2013 Apr; 27(4):1439-49. PubMed ID: 23271052
[TBL] [Abstract][Full Text] [Related]
7. Plin5 deficiency exacerbates pressure overload-induced cardiac hypertrophy and heart failure by enhancing myocardial fatty acid oxidation and oxidative stress.
Wang C; Yuan Y; Wu J; Zhao Y; Gao X; Chen Y; Sun C; Xiao L; Zheng P; Hu P; Li Z; Wang Z; Ye J; Zhang L
Free Radic Biol Med; 2019 Sep; 141():372-382. PubMed ID: 31291602
[TBL] [Abstract][Full Text] [Related]
8. Rnd3 haploinsufficient mice are predisposed to hemodynamic stress and develop apoptotic cardiomyopathy with heart failure.
Yue X; Yang X; Lin X; Yang T; Yi X; Dai Y; Guo J; Li T; Shi J; Wei L; Fan GC; Chen C; Chang J
Cell Death Dis; 2014 Jun; 5(6):e1284. PubMed ID: 24901055
[TBL] [Abstract][Full Text] [Related]
9. Crucial role of ROCK2 in vascular smooth muscle cells for hypoxia-induced pulmonary hypertension in mice.
Shimizu T; Fukumoto Y; Tanaka S; Satoh K; Ikeda S; Shimokawa H
Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2780-91. PubMed ID: 24135024
[TBL] [Abstract][Full Text] [Related]
10. Isolevuglandin scavenger attenuates pressure overload-induced cardiac oxidative stress, cardiac hypertrophy, heart failure and lung remodeling.
Shang L; Weng X; Wang D; Yue W; Mernaugh R; Amarnath V; Weir EK; Dudley SC; Xu Y; Hou M; Chen Y
Free Radic Biol Med; 2019 Sep; 141():291-298. PubMed ID: 31254620
[TBL] [Abstract][Full Text] [Related]
11. Targeted deletion of ROCK1 protects the heart against pressure overload by inhibiting reactive fibrosis.
Zhang YM; Bo J; Taffet GE; Chang J; Shi J; Reddy AK; Michael LH; Schneider MD; Entman ML; Schwartz RJ; Wei L
FASEB J; 2006 May; 20(7):916-25. PubMed ID: 16675849
[TBL] [Abstract][Full Text] [Related]
12. Crucial role of rho-kinase in pressure overload-induced right ventricular hypertrophy and dysfunction in mice.
Ikeda S; Satoh K; Kikuchi N; Miyata S; Suzuki K; Omura J; Shimizu T; Kobayashi K; Kobayashi K; Fukumoto Y; Sakata Y; Shimokawa H
Arterioscler Thromb Vasc Biol; 2014 Jun; 34(6):1260-71. PubMed ID: 24675663
[TBL] [Abstract][Full Text] [Related]
13. Extracellular high-mobility group box 1 mediates pressure overload-induced cardiac hypertrophy and heart failure.
Zhang L; Liu M; Jiang H; Yu Y; Yu P; Tong R; Wu J; Zhang S; Yao K; Zou Y; Ge J
J Cell Mol Med; 2016 Mar; 20(3):459-70. PubMed ID: 26647902
[TBL] [Abstract][Full Text] [Related]
14. Cardiomyocyte-specific ablation of CD36 accelerates the progression from compensated cardiac hypertrophy to heart failure.
Sung MM; Byrne NJ; Kim TT; Levasseur J; Masson G; Boisvenue JJ; Febbraio M; Dyck JR
Am J Physiol Heart Circ Physiol; 2017 Mar; 312(3):H552-H560. PubMed ID: 28062415
[TBL] [Abstract][Full Text] [Related]
15. Glucose is preferentially utilized for biomass synthesis in pressure-overloaded hearts: evidence from fatty acid-binding protein-4 and -5 knockout mice.
Umbarawan Y; Syamsunarno MRAA; Koitabashi N; Yamaguchi A; Hanaoka H; Hishiki T; Nagahata-Naito Y; Obinata H; Sano M; Sunaga H; Matsui H; Tsushima Y; Suematsu M; Kurabayashi M; Iso T
Cardiovasc Res; 2018 Jul; 114(8):1132-1144. PubMed ID: 29554241
[TBL] [Abstract][Full Text] [Related]
16. Eicosapentaenoic acid suppresses adverse effects of C-reactive protein overexpression on pressure overload-induced cardiac remodeling.
Nagai T; Anzai T; Mano Y; Kaneko H; Anzai A; Sugano Y; Maekawa Y; Takahashi T; Yoshikawa T; Fukuda K
Heart Vessels; 2013 May; 28(3):404-11. PubMed ID: 22875408
[TBL] [Abstract][Full Text] [Related]
17. Midkine exacerbates pressure overload-induced cardiac remodeling.
Netsu S; Shishido T; Kitahara T; Honda Y; Funayama A; Narumi T; Kadowaki S; Takahashi H; Miyamoto T; Arimoto T; Nishiyama S; Watanabe T; Woo CH; Takeishi Y; Kubota I
Biochem Biophys Res Commun; 2014 Jan; 443(1):205-10. PubMed ID: 24291499
[TBL] [Abstract][Full Text] [Related]
18. Disruption of ROCK1 gene attenuates cardiac dilation and improves contractile function in pathological cardiac hypertrophy.
Shi J; Zhang YW; Summers LJ; Dorn GW; Wei L
J Mol Cell Cardiol; 2008 Mar; 44(3):551-60. PubMed ID: 18178218
[TBL] [Abstract][Full Text] [Related]
19. Disruption of both ROCK1 and ROCK2 genes in cardiomyocytes promotes autophagy and reduces cardiac fibrosis during aging.
Shi J; Surma M; Yang Y; Wei L
FASEB J; 2019 Jun; 33(6):7348-7362. PubMed ID: 30848941
[TBL] [Abstract][Full Text] [Related]
20. Crucial Role of ROCK2-Mediated Phosphorylation and Upregulation of FHOD3 in the Pathogenesis of Angiotensin II-Induced Cardiac Hypertrophy.
Zhou Q; Wei SS; Wang H; Wang Q; Li W; Li G; Hou JW; Chen XM; Chen J; Xu WP; Li YG; Wang YP
Hypertension; 2017 Jun; 69(6):1070-1083. PubMed ID: 28438902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
